Hikal Limited (NSE:HIKAL)
India · Delayed Price · Currency is INR 267.85
-1.70 (-0.63%)
Aug 12, 2025, 3:30 PM IST
Hikal Employees
Hikal had 2,061 employees as of March 31, 2024. The number of employees decreased by 81 or -3.78% compared to the previous year.
Employees
2,061
Change (1Y)
-81
Growth (1Y)
-3.78%
Revenue / Employee
8.90M INR
Profits / Employee
307.13K INR
Market Cap
33.07B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 2,061 | -81 | -3.78% |
| Mar 31, 2023 | 2,142 | 236 | 12.38% |
| Mar 31, 2022 | 1,906 | 378 | 24.74% |
| Mar 31, 2021 | 1,528 | -101 | -6.20% |
| Mar 31, 2020 | 1,629 | 42 | 2.65% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 42,497 |
| Mankind Pharma | 26,978 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Aurobindo Pharma | 26,015 |
Hikal News
- 5 days ago - Hikal shares fall nearly 7% after Q1 loss of Rs 22.4 crore - Business Upturn
- 5 days ago - Hikal reports Q1 net loss of Rs 22.4 crore; revenue declines 6.5% YoY - Business Upturn
- 2 months ago - Hikal successfully clears ANVISA GMP audit for Bengaluru API manufacturing facility - Business Upturn
- 2 months ago - Hikal receives OAI classification from US FDA for Jigani facility - Business Upturn
- 3 months ago - Hikal share price jumps 4% as Q4 revenue rises 7.4% YoY to Rs 552 crore, net profit up 48% YoY - Business Upturn
- 3 months ago - Hikal Q4 Results: Revenue up 7.4% YoY to Rs 552 crore, Net Profit up 48% YoY - Business Upturn
- 6 months ago - Hikal shares drop over 6% after US FDA issues six observations for Jigani facility - Business Upturn
- 6 months ago - Hikal receives 6 observations for Jigani facility from US FDA - Business Upturn